Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cigna Group Director's Dealing 2020

Mar 3, 2020

29918_dirs_2020-03-02_727ebe2b-6677-45b2-b1e4-0744e380725d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-02-27

Reporting Person: Manders Matthew G (President, Strategy & Solution)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-27 Common Stock, $.01 Par Value F 548.0000 $185.7600 Disposed 46018.0000 Direct
2020-02-28 Common Stock, $.01 Par Value A 6305.0000 $0.0000 Acquired 52323.0000 Direct
2020-02-28 Common Stock, $.01 Par Value F 2336.0000 $179.4100 Disposed 49987.0000 Direct
2020-03-02 Common Stock, $.01 Par Value S 3969.0000 $182.8500 Disposed 46018.0000 Direct

Footnotes

F1: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F2: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.